IP Library Granted Patent US 8,788,034
Granted Patent B2
US 8,788,034 · App. 13/467,928 · Granted Jul 22, 2014

Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation

Inventors: Jacob A. Levine (Queens, NY); Michael A. Faltys (Valencia, CA)
Assignee: SetPoint Medical Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,788,034
App. No.
13/467,928
Granted
Jul 22, 2014
Kind
B2
Abstract

Described herein are methods and systems for applying extremely low duty-cycle stimulation sufficient to treat chronic inflammation. In particular, described herein are single supra-threshold pulses of electrical stimulation sufficient to result in a long-lasting (e.g., >4 hours, greater than 12 hours, greater than 24 hours, greater than 48 hours) inhibition of pro-inflammatory cytokines and/or effects of chronic inflammation. These methods and devices are particularly of interest in treatment of inflammatory bowel disease (IBD).

Claims (25)

1. A system for treating chronic inflammation in a patient, the system comprising:

an implantable microstimulator configured to apply a low duty-cycle stimulation to a vagus nerve, wherein the low duty-cycle stimulation provides no more than a single supra-threshold pulse every four hours; and

a controller configured to set a dose for the microstimulator wherein the dose comprises the single supra-threshold pulse followed by an off-period of at least four hours, wherein the single supra-threshold pulse is configured to reduce a level of inflammation in the patient.

2. The system of claim 1 , wherein the off-period is at least 24 hours.

3. The system of claim 1 , wherein the off-period is at least 48 hours.

4. The system of claim 1 , wherein the single supra-threshold pulse has a pulse amplitude of less than 5 mA.

5. The system of claim 1 , wherein the single supra-threshold pulse has a pulse amplitude of less than 3 mA.

6. The system of claim 1 , wherein the single supra-threshold pulse has a pulse amplitude of less than 2 mA.

7. The system of claim 1 , wherein the single supra-threshold pulse is biphasic.

8. The system of claim 1 , wherein the chronic inflammation is intestinal inflammation.

9. The system of claim 1 , wherein the chronic inflammation is inflammatory bowel disease.

10. The system of claim 1 , wherein the chronic inflammation is Crohn's disease.

11. A method of treating chronic inflammation in a patient, the method comprising:

implanting a microstimulator; and

applying only a single supra-threshold stimulus pulse from the microstimulator to the vagus nerve followed by an off-time of at least 4 hours; and

reducing a level of inflammation in the patient.

12. The method of claim 11 , wherein the off-time is at least 24 hours.

13. The method of claim 11 , wherein the off-time is at least 48 hours.

14. The method of claim 11 , wherein the single supra-threshold stimulus pulse has a pulse amplitude of less than 5 mA.

15. The method of claim 11 , wherein the single supra-threshold stimulus pulse has a pulse amplitude of less than 3 mA.

16. The method of claim 11 , wherein the single supra-threshold stimulus pulse has a pulse amplitude of less than 2 mA.

17. The method of claim 11 , wherein the single supra-threshold stimulus pulse is biphasic.

18. The method of claim 11 , wherein the chronic inflammation is intestinal inflammation.

19. The method of claim 11 , wherein the chronic inflammation is inflammatory bowel disease.

20. The method of claim 11 , wherein the chronic inflammation is Crohn's disease.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2012
From: LEVINE, JACOB A.; FALTYS, MICHAEL A.
To: SETPOINT MEDICAL CORPORATION
Reel/Frame 029409/0674 →
Continuity (2)
Provisional Application 61484112 · May 9, 2011
Related Publication 20120290035A1 · Nov 15, 2012